Based on pooled results of early COVID-19 data, chronic liver disease seems to play a minor role in influencing patient progression towards the severe form of disease. A non-significant trend towards increased odds of mortality in COVID-19 patients with chronic liver disease should continue to be evaluated in larger studies. Therefore, data to-date would not apparently support the inclusion of chronic liver disease into risk stratification models as clinical predictor of severe disease.
|Titolo:||Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis|
|Data di pubblicazione:||2021|
|Appare nelle tipologie:||01.01 Articolo in Rivista|